NOF's 2013 Clinician's Guide contains updated guidance on vertebral fracture assessment and the use of biochemical markers of bone turnover, as well as updated information on calcium, vitamin D and medications. This useful guide is a must to inform clinical decision-making to manage the diagnosis and treatment of men and women at high risk for fractures.
The 2010 Clinician's Guide is also available as a downloadable document. To view the medication addendum to the 2010 version, visit Clinician's Guide Addendum: denosumab (Prolia®)